7:00 am Networking 8:00 am Supercharging Fundamental Knowledge & Understanding of CAR-TCR Biology & Immunological Function Stanley Frankel Chief Medical Officer, Cytovia Tony Ho Industry Expert, Self Employed, Previously CRISPR Therapeutics Jens Hasskarl Chief Medical Officer, Tigen Pharma 10:00 am Networking 10:30 am Overcoming Mechanisms of Treatment Resistance of CAR-TCR Engineered T-Cells in Solid Tumors Daniel Powell Associate Professor of Pathology & Lab Medicine, University of Pennsylvania Eric Von Hofe Senior Advisor, AffyImmune 12:30 pm Lunch 1:30 pm Exploring the Advantages & Applications of CAR-T Technology Beyond Oncology Miloš Miljković Chief Medical Officer, Cartesian Therapeutics Marko Radic Associate Professor of Microbiology, Immunology & Biochemistry , University of Tennessee Health Science Center Samik Basu Chief Scientific Officer, Cabaletta Bio 3:30 pm Networking 4:00 pm CAR-TCR Think-Tank Luis Borges Chief Scientific Officer, Century Therapeutics Helen Tayton-Martin Chief Business Officer, Adaptimmune Adrian Bot Chief Scientific Officer & Executive Vice President, Research & Development, Capstan Therapeutics 4:00 pm Investors Roundtable 5:00 pm Diversity in CAR-TCR Nushmia Khokhar Chief Medical Officer, Umoja Biopharma Angela Justice Chief People Officer, TCR2 Brad Hartman Chief People Officer, Be Biopharma 6:30 pm Ambassador Reception hosted by Precision Advance
